357 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
Rank Status Study
21 Recruiting Strategies for Ovulation Induction in Anovulatory Infertile Patients With PCOS
Condition: Anovulatory Infertility Related to Polycystic Ovary Syndrome
Intervention: Drug: Clomiphene citrate, metformin, metformin plus clomiphene citrate, gonadotropins
22 Recruiting Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: HIV Infection;   Recurrent Anal Cancer;   Recurrent Breast Cancer;   Recurrent Esophageal Cancer;   Recurrent Gastric Cancer;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Salivary Gland Squamous Cell Carcinoma;   Stage IV Anal Cancer;   Stage IV Breast Cancer;   Stage IV Esophageal Cancer;   Stage IV Gastric Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IV Verrucous Carcinoma of the Oral Cavity;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: vorinostat;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study;   Drug: carboplatin;   Drug: paclitaxel
23 Unknown  The Role of Insulin Resistance in PCOS
Conditions: Polycystic Ovary Syndrome;   Insulin Resistance;   Obesity
Intervention:
24 Recruiting Autologous Stem Cells Transplantation in Patients With Idiopathic and Drug Induced Premature Ovarian Failure
Condition: Premature Ovarian Failure
Intervention: Biological: Biological: Stem Cells
25 Recruiting Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients
Conditions: Breast Cancer;   Ovarian Cancer
Interventions: Biological: E39 peptide vaccine;   Biological: E39 vaccine then J65 vaccine;   Biological: J65 vaccine then E39 vaccine
26 Unknown  GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation
Condition: Infertile High-risk Patients With Polycystic Ovaries
Intervention: Drug: a drug withdrawal during the long protocol
27 Recruiting EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Paclitaxel + Carboplatin every 3 weeks;   Drug: Carboplatin monotherapy every 3 weeks;   Drug: Weekly Paclitaxel and Carboplatin
28 Recruiting Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer
Conditions: Advanced Breast Carcinoma;   Advanced Ovarian Carcinoma
Intervention: Biological: ONT-10, Varlilumab combination
29 Recruiting Oxidative Stress and Bisphenol A (BPA) Impact With Polycystic Ovary Syndrome (PCOS)
Conditions: Oxidative Stress;   Endocrine Disrupting Chemicals;   Polycystic Ovary Syndrome
Intervention:
30 Unknown  Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy
Condition: Ovarian Carcinoma
Intervention: Drug: Cytophosphan, Celecoxib, Methotrexate
31 Recruiting Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer
Conditions: Relapsed Epithelial Ovarian Cancer;   Relapsed Primary Peritoneal Cancer;   Relapsed Fallopian Tube Cancer
Interventions: Drug: Birinapant;   Drug: Conatumumab
32 Recruiting Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Procedure: Secondary debulking;   Procedure: secondary debulking with intraperitoneal chemotherapy
33 Recruiting A Study of LY2228820 for Recurrent Ovarian Cancer
Conditions: Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Interventions: Drug: LY2228820;   Drug: Carboplatin;   Drug: Placebo;   Drug: Gemcitabine
34 Recruiting Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
Conditions: Ovarian Cancer;   Cancer of Ovary;   Cancer of the Ovary;   Ovary Neoplasms;   Primary Peritoneal Carcinoma
Intervention: Drug: Fenretinide/LXS + Ketoconazole
35 Recruiting Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy
Conditions: Ovarian Carcinoma;   Fallopian Tube Carcinoma;   Primary Peritoneal Carcinoma
Intervention: Procedure: HIPEC
36 Recruiting Androgen Metabolism and Reproductive Outcome
Conditions: Polycystic Ovary Syndrome;   Healthy Pregnant Women
Intervention:
37 Recruiting Effect of Weight and Insulin Sensitivity on Reproductive Function in Polycystic Ovary Syndrome:Studies in Skeletal Muscle and Adipose Tissue
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Metformin;   Behavioral: Exercise;   Behavioral: Dietary Restriction
38 Unknown  Meal Timing on Glucose and Hyperandrogenism in PCOS Women
Condition: Polycystic Ovary Syndrome (PCOS) Women
Interventions: Behavioral: Placebo Comparator: Lifestyle counseling Dinner Diet ARM 2;   Other: Active Comparator: Lifestyle counseling ARM 1
39 Not yet recruiting Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations
Condition: Platinum Sensitive Relapsed Ovarian Cancer
Interventions: Drug: OLAPARIB;   Other: PLACEBO
40 Recruiting Observational Epidemiologic Study in Women With Premature Ovarian Failure (POF)
Condition: Primary Ovarian Insufficiency
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years